Articles by: Jerome BurneJerome Burne

New blueprint for Cancer Treatment

3 by / on 2 Mar 2019, / in cancer

By Jerome Burne How to Starve […]

Latest statin scam | Mis-selling them to pensioners

10 by / on 11 Feb 2019, / in statins

By Jerome Burne The blog has […]

How the UK press published hundreds of fake news stories about cancer drugs

3 by / on 17 Sep 2018, / in cancer

By Jerome Burne Last week the […]

QOF Fiasco 2: ’Immoral’ refusal to learn from mistakes

7 by / on 28 May 2018, / in evidence based medicine

By Jerome Burne Last week I […]

The great QOF fiasco. The untold story of the biggest public health experiment ever and how its failure was ignored.

12 by / on 14 May 2018, / in evidence based medicine, lifestyle medicine

By Jerome Burne The results of […]

Oncology or Ecology (Part 2)

7 by / on 24 Apr 2018, / in cancer

By Jerome Burne Last week’s post […]

Oncology or Ecology (Part 1)

4 by / on 18 Apr 2018, / in cancer

By Jerome Burne An article published […]

Low fat blinkers keep low carbs in the cold. Time for a coalition.

8 by / on 22 Jan 2018, / in low carb diet

If the low carb diet was a political party, it should be now be close to forming a government. Its story mirrors that of actual parties – founded decades ago, it was small for a long time, languishing on the fringes of respectability; its policies were dismissed as untested and possibly dangerous by the low-fat ruling party which had close links to big business.

Healthy Eating: The Big Mistake by Dr Verner Wheelock with Marika Sboros (Columbus Publishing £12.99)

3 by / on 8 Jan 2018, / in low carb diet

‘I wish they’d make up their minds,’ you may find yourself muttering if you don’t follow healthy eating debates all that closely. ‘One moment they tell us to stop eating butter and eggs on pain of having a heart attack and to have marge and no more than an egg a week.

The straight case for mind bending

12 by / on 29 Nov 2017, / in Psychiatric drugs

A couple of weeks ago I wrote about a remarkable study, just published in the BMJ which had found that over half of the new cancer drugs released onto the market in a four year period by the EU drugs regulator had no good evidence that they were effective. In other words, there was also no evidence that their benefits outweighed their risk or that they were value for money.

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann